🚀 We’re heading to ERS 2025!
See N-Tidal Diagnose, our newly released AI-powered test for COPD, meet our science team, and hear how AI/ML is driving diagnostic accuracy.
📢 Don’t miss our Lead ML Engineer on Sept 28 | 12:30 | PS-15 #ERS2025
Live from #COPDUK2025:
Speakers are underlining the opportunity—and urgent need—to transform the COPD diagnostic pathway for earlier, more accessible, and accurate diagnosis.
@TidalSense is ready to lead the way. #COPD#DigitalHealth
TidalSense is joining #COPDUK2025, 10-11 July in Nottingham! We're proud to support advances in early diagnosis & digital health in COPD care. Let’s connect! 🫁 #COPDUK2025#COPD #DigitalHealth#Diagnostic#TidalSense
We’ve just achieved Cyber Essentials Plus certification!
Independently audited, NHS-ready, and proof that we take cyber security as seriously as we take digital health.
#CyberSecurity#NHS#HealthTech#CyberEssentialsPlus
We are thrilled to be part of the @EuroRespSoc showcasing TidalSense's technologies at #ERSCongress 2024!
Join us at stand D3.07 from September 7-11 to see N-Tidal in action!
Let's connect and transform the future of healthcare together. #ERSCongress
So exciting to see innovation like this developed to simplify + speed up COPD diagnosis. A fantastic article by @DrErikaK in @guardian about @TidalSense's N-Tidal handheld device which aims to diagnose COPD in under 5 minutes (!) using a recording of normal, relaxed breathing
We urgently need diagnosis to improve for people with lung conditions. This is why we’re working with @TidalSense on their N-Tidal device which uses AI to improve the speed and accessibility of COPD diagnosis. Find out more:
https://t.co/npwgwuCHDj
We're collaborating with the NHS to develop educational resources that train healthcare professionals on AI-powered diagnostic tools like our N-Tidal Diagnose — for faster, more accessible COPD diagnosis. #Healthcare#AI#Innovation
Read more: https://t.co/3xCsbK3N7U
Pleased to have @tidalsense at #NHSConfedExpo.
TidalSense is on a mission to revolutionise respiratory care pathways. The N-Tidal Diagnose medical device (2a EUMDR regulatory clearance expected Q4 2024) will deliver quick, accurate, AI powered point-of-care COPD diagnosis.
Join TidalSense at the ATS Conference in San Diego! We are proud to be an RIS 2024 Poster Company this year #RIS2024.
If you are going to #ATS2024 we’d love to connect in person and share our vision for revolutionising respiratory healthcare with our N-Tidal technology.
Research alert 🚨 TidalSense publishes pivotal paper showing how N-Tidal can be used to diagnose all severities of COPD (not just severe disease). Read more: #COPD#innovation#healthtech
A new research paper from @TidalSense has revealed how new medical devices, combined with advanced machine learning techniques, could offer a promising alternative to traditional spirometry for diagnosing #COPD https://t.co/sSmuEUJ9WZ #medtech
🌟 Exciting Research Alert! 🌟
Big thanks to @sbrihealthcare for backing our N-Tidal device study. Aimed at revolutionising paediatric respiratory care, this project targets better diagnosis & monitoring of asthma and viral wheeze in kids under five.
Join Ameera Patel at the Westminster Health Respiratory Forum online today. She’ll discuss the future of respiratory care, including innovative approaches to identifying and diagnosing patients.
#WHFEVENTS#Respiratory#AI
Dr @ameeraxpatel highlights the overlooked mental toll of asthma on children under 5. Early diagnosis & awareness are key to addressing this silent crisis. Let's protect our little ones' mental & physical health